Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Johnson & Johnson (JNJ)

Johnson & Johnson (JNJ)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 424,619,360
  • Shares Outstanding, K 2,632,482
  • Annual Sales, $ 82,584 M
  • Annual Income, $ 14,714 M
  • 60-Month Beta 0.73
  • Price/Sales 5.10
  • Price/Cash Flow 14.70
  • Price/Book 6.06
Trade JNJ with:

Options Overview Details

View History
  • Implied Volatility 18.42%
  • Historical Volatility 11.70%
  • IV Percentile 52%
  • IV Rank 26.98%
  • IV High 33.44% on 10/30/20
  • IV Low 12.87% on 09/03/21
  • Put/Call Vol Ratio 0.78
  • Today's Volume 45,022
  • Volume Avg (30-Day) 20,140
  • Put/Call OI Ratio 0.69
  • Today's Open Interest 332,879
  • Open Int (30-Day) 324,545

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 10 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/21
See More
  • Average Estimate 2.37
  • Number of Estimates 7
  • High Estimate 2.52
  • Low Estimate 2.26
  • Prior Year 2.20
  • Growth Rate Est. (year over year) +7.73%

Price Performance

See More
Period Period Low Period High Performance
1-Month
157.34 +2.52%
on 10/12/21
166.46 -3.10%
on 09/16/21
-4.12 (-2.49%)
since 09/15/21
3-Month
157.34 +2.52%
on 10/12/21
179.92 -10.35%
on 08/20/21
-7.07 (-4.20%)
since 07/15/21
52-Week
133.65 +20.69%
on 10/30/20
179.92 -10.35%
on 08/20/21
+14.11 (+9.59%)
since 10/15/20

Most Recent Stories

More News
The Latest: Fauci dismayed by Texas' move to ban mandates

WASHNGTON — Dr. Anthony Fauci is saying Sunday that it is “really unfortunate” that Gov. Greg Abbott has moved to ban vaccine mandates in the state of Texas.

PFE : 41.49 (-0.43%)
JNJ : 161.30 (+0.74%)
The Latest: Russia's daily virus death toll passes 1,000

MOSCOW — Russia’s daily death toll from COVID-19 has exceeded 1,000 for the first time as the country faces a sustained wave of rising infections.

PFE : 41.49 (-0.43%)
JNJ : 161.30 (+0.74%)
The Latest: Maine vaccine mandate opponents file appeal

MAINE — Opponents of a COVID-19 vaccine mandate for health care workers in Maine filed an emergency appeal to the U.S. Supreme Court after being dealt another legal defeat on Friday.

PFE : 41.49 (-0.43%)
JNJ : 161.30 (+0.74%)
Into the Heart of Q3 Earnings Season

The big banks got us off to a flying start in this Q3 earnings season, but we will get a true sense of how good or otherwise the corporate profitability picture is after seeing the coming week's reporting...

INTC : 54.46 (+1.04%)
JNJ : 161.30 (+0.74%)
NFLX : 628.29 (-0.87%)
PG : 144.42 (+0.26%)
TSLA : 843.03 (+3.02%)
SNAP : 77.34 (+0.91%)
FDA panel endorses booster shot for J&J COVID-19 vaccine

WASHINGTON (AP) — U.S. health advisers endorsed a booster of Johnson & Johnson’s COVID-19 vaccine Friday, citing concern that Americans who got the single-dose shot aren’t as protected as those given...

JNJ : 161.30 (+0.74%)
PFE : 41.49 (-0.43%)
Stocks end higher, giving S&P 500 its best week since July

Wall Street added to its recent gains Friday as stocks closed higher, driving the S&P 500 to its best week since July.

SNE : 106.01 (+1.44%)
$SPX : 4,471.37 (+0.75%)
$DOWI : 35,294.76 (+1.09%)
$IUXX : 15,146.92 (+0.63%)
JNJ : 161.30 (+0.74%)
ARNC : 31.73 (+1.08%)
TSLA : 843.03 (+3.02%)
UNH : 428.07 (+1.83%)
Housing Information out Next Week as October Winds Down

Monday U.S. Economic Lookahead Industrial production (Sept.) Capacity utilization rate (Sept.) National ...

IBM : 144.61 (+0.85%)
STT : 92.73 (+1.11%)
JNJ : 161.30 (+0.74%)
PG : 144.42 (+0.26%)
NFLX : 628.29 (-0.87%)
TSLA : 843.03 (+3.02%)
ASML : 789.40 (+1.43%)
VZ : 52.27 (+0.67%)
DHR : 301.38 (+0.32%)
INTC : 54.46 (+1.04%)
T : 25.70 (+0.31%)
HON : 220.72 (+0.97%)
AXP : 175.81 (+2.51%)
HCA : 246.88 (+1.80%)
CNR.TO : 151.67 (+0.78%)
FURY.TO : 0.88 (-2.22%)
CP.TO : 90.20 (+1.83%)
Johnson & Johnson COVID-19 Vaccine Booster Shot Unanimously Recommended for Emergency Use Authorization by U.S. FDA Advisory Committee

/PRNewswire/ -- Johnson & Johnson (NYSE: JNJ) (the Company) today announced the U.S. Food and Drug Administration's (FDA) Vaccines and Related Biological...

JNJ : 161.30 (+0.74%)
FDA advisory panel endorses booster doses of Johnson & Johnson’s single-shot COVID-19 vaccine

WASHINGTON (AP) — FDA advisory panel endorses booster doses of Johnson & Johnson’s single-shot COVID-19 vaccine.

JNJ : 161.30 (+0.74%)
Novavax (NVAX) Lags in COVID Vaccine Race: Will It Gather Pace?

Novavax (NVAX) is progressing well with its COVID-19 and flu vaccines. However, it is lagging in the COVID-19 vaccine space. Let us see how the company is likely to perform going forward.

JNJ : 161.30 (+0.74%)
PFE : 41.49 (-0.43%)
MRNA : 324.21 (-2.31%)
NVAX : 161.95 (-4.59%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 40% Sell with a Weakening short term outlook on maintaining the current direction.

See More Share

Business Summary

Johnson & Johnson is engaged in the research and development, manufacture and sale of a range of products in the healthcare field. The Company operates in three segments: Consumer, Pharmaceutical, and Medical Devices and Diagnostics. Its Consumer segment offers products for use in the baby care, skin...

See More

Key Turning Points

3rd Resistance Point 163.34
2nd Resistance Point 162.57
1st Resistance Point 161.94
Last Price 161.30
1st Support Level 160.54
2nd Support Level 159.77
3rd Support Level 159.14

See More

52-Week High 179.92
Fibonacci 61.8% 162.24
Last Price 161.30
Fibonacci 50% 156.79
Fibonacci 38.2% 151.33
52-Week Low 133.65

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar